In times of crisis, it is good to have a partner like Oost NL. Where possible they show financial leniency and they bring proactive other support options to our attention.
An estimated 4 million women need a blood transfusion after giving birth annually. Now new research has found that their pregnancies put these women are at a higher risk of …
8 April 2020, Zwolle – In the fight against COVID-19, HemoClear’s current top priority is to help save lives, with COVID-19 convalescent plasma therapy. In spite of the incredibly global …
The persisting coronavirus epidemic is drying up Asian blood banks, further increasing the global blood shortage. Blood supplies fail the demand for emergency aid and other transfusion treatments. As a …
How Mohammed Kamruzzaman’s blood transfusion supports the preference for autologous blood for blood transfusion Autologous blood (patients’ own blood) is an invaluable source of transfusion blood. Especially when donor blood …
It was a pleasure to define with the experts of Task Force Healthcare and successful entrepreneur in international markets Willem van Prooijen, some valuable and practical improvements to HemoClear’s international …
A patient’s own salvaged red blood cells (autologous red blood cells) are functionally superior to donated red blood cells. This is the first out of seven reasons why autologous blood should be …
HemoClear and Pennine Healthcare team up to develop and manufacture a complete ready-to-use HemoClear accessories kit. The kit contains all material to recuperate red blood cells from patient shed blood, …
Important research quantifies the global scarcity of life-saving donor blood. As a result an estimated 10 million patients unnecessarily suffer or die annually . This is caused by a 30 …
Last week at the Medica in Dusseldorf, HemoClear and Medista signed an distribution agreement. In this agreement we assign the exclusive commercial distribution rights for the Czech Republic to Medista. …